Project description
A novel skincare laser against hyperpigmentation
Birthmarks and pigmentation disorders such as melasma or freckles may be distressing for many people. Skin examination and often biopsy are undertaken to exclude the possibility of melanoma. Hyperpigmentation is treated using various methods such as light or laser therapy, which target the affected area. The EU-funded LIGHTSENSE project is introducing a non-thermal ablative laser to improve skincare and advance hyperpigmentation treatment. Initially developed for removing tattoos, the LIGHTSENSE technology is now also aimed at many skin conditions. The project is supporting a feasibility study for validating the technological performance of the new laser, accompanied by commercial and financial strategy planning.
Objective
LightSense Technologies has developed and patented an innovative, non thermal ablative laser which constitutes a leap forward in laser technology with the potential to dramatically improve laser skincare and position Europe as a leader in medical and aesthetic applications. We are initially focused on tattoo removal because (1) the market is very large and growing, and well defined with clear patient needs, (2) the competitive offering is terrible, and (3) we have already developed meaningful intellectual property in this specific application with approved patents to support our work. We intend to quickly expand beyond tattoo removal, establishing industry-wide and academically-recognized laser solutions for many dermatology applications. We will begin by validating our business plan through the implementation of a Feasibility Study. The study will aim to better understand (A) technology performance in different laser-skin tissue studies, (B) commercial research with key stakeholders, and (C) financial strategy definition, as explained below. With this information, we will improve our laser tattoo removal treatment and refine our go-to- market strategy. LightSense Technologies forecasts ~€30M in revenues by 2021 (~€800M by 2030). Projections take in consideration an average price of € 2,850 per treatment, assuming a decrease thereafter.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences clinical medicine dermatology
- social sciences economics and business business and management business models
- natural sciences physical sciences optics laser physics
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3. - PRIORITY 'Societal challenges
See all projects funded under this programme -
H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-EIC-SMEInst-2018-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
N12 0BP London
United Kingdom
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.